These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30685923)

  • 1. [Experimental study of silybin-phospholipid complex intervention on amiodarone-induced fatty liver in mice].
    Sun SS; Wu YX; Cheng ML; Chen CW; Peng YS; Miao Q; Bian ZL; Wang XJ; Fu QC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):45-50. PubMed ID: 30685923
    [No Abstract]   [Full Text] [Related]  

  • 2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of silybin on high-fat-induced fatty liver in rats.
    Yao J; Zhi M; Minhu C
    Braz J Med Biol Res; 2011 Jul; 44(7):652-9. PubMed ID: 21755261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sennoside A protects mitochondrial structure and function to improve high-fat diet-induced hepatic steatosis by targeting VDAC1.
    Le J; Jia W; Sun Y
    Biochem Biophys Res Commun; 2018 Jun; 500(2):484-489. PubMed ID: 29673597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
    Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
    Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
    Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
    World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulatory Effect of Qushi Huayu Recipe on Gene Expression Profiles of Fatty Liver Rats].
    Feng Q; Tang YJ; Li XF; Meng SX; Peng JH; Zhao Y; Hu YY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Feb; 36(2):203-9. PubMed ID: 27078998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats].
    Shen WD; Zhang W; Xu QH; Liu PF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):749-754. PubMed ID: 27938560
    [No Abstract]   [Full Text] [Related]  

  • 11. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.
    Serviddio G; Bellanti F; Giudetti AM; Gnoni GV; Petrella A; Tamborra R; Romano AD; Rollo T; Vendemiale G; Altomare E
    J Pharmacol Exp Ther; 2010 Mar; 332(3):922-32. PubMed ID: 20008062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
    Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice.
    Sundaresan A; Radhiga T; Pugalendi KV
    Eur J Pharmacol; 2014 Oct; 741():297-303. PubMed ID: 25149666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
    Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
    J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Amiodarone Lipotoxicity Is Ameliorated by Genetic and Pharmacological Inhibition of Endoplasmatic Reticulum Stress.
    Erez N; Hubel E; Avraham R; Cohen R; Fishman S; Bantel H; Manns M; Tirosh B; Zvibel I; Shibolet O
    Toxicol Sci; 2017 Oct; 159(2):402-412. PubMed ID: 28962527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
    Wang X; He H; Liang LB; Zhang M; Li SY; Li SQ; An ZM; Huang HJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):28-32. PubMed ID: 28612554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.